Ron Scarboro, Azurity Pharmaceuticals, explains how cross-functional development, disciplined reformulation, and post-approval metrics can help proven medicines work in everyday use.
News|Articles|March 20, 2020
GEA Launches New Twin-screw Pumps for Hygienic Applications
GEA began supplying the new GEA Hilge Novatwin hygienic twin-screw pump line.
The GEA Hilge Novatwin hygienic, stainless-steel twin-screw pump, part of the GEA Varipump line, is now available in six sizes. GEA says the pump can be used for pharmaceutical products including nutraceuticals, blood products, vaccines, enzymes, and cell cultures.
Twin-screw pumps are positive displacement pumps and offer gentle conveyance of shear-sensitive and abrasive media; they can also pump liquids of different viscosities. The pumps can also be operated at high speeds for functioning as a clean-in-place (CIP) pump.
According to the press release, the self-priming GEA Hilge Novatwin enables safe operation with low pulsation and low noise levels at high product viscosities, temperatures up to 135 °C, and differential pressures up to 25 bar. The system pressure of 30 bar also allows the pump to be used in high-pressure applications. The pump handles both sensitive, viscous media at low speed and cleaning media in the CIP process at up to 3000 rpm.
Source:
Related to this article
This week, drug formulation and manufacturing experts showcased their knowledge, and companies exhibited their products, at CPHI Milan.
FDA approves Teva’s Weltruza, a once-monthly subcutaneous olanzapine for schizophrenia whose copolymer depot eliminates post-injection monitoring.
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Jason Bertola, executive director of Commercial Development for the Advanced Synthesis Platform at Lonza in North America, explains the demand for spray drying and the hurdles involved with scale up, in an interview with PharmTech.
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Trending on Pharmaceutical Technology
1
Pritelivir Shifts Resistant Herpes Care from Intravenous to Oral
2
Manufacturing Intelligence: Organoids, Organ-on-a-Chip, and the Trust Gap
3
Complying with International Pharmacopoeias
4
CPHI Milan: Packaging and Delivery Decisions Must Reflect Real-World Care
5